<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Comorbidities and complications of epilepsy in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Comorbidities and complications of epilepsy in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Comorbidities and complications of epilepsy in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven C Schachter, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Garcia, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Dashe, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H373733909"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Epilepsy is a chronic disease associated with an increased risk of a variety of psychiatric and medical comorbidities that can adversely affect quality of life as well as life expectancy. Comorbidities can arise due to common underlying predispositions, direct effects of seizures, underlying epilepsy etiologies, and adverse effects of antiseizure medications and other therapies. Depression and anxiety are particularly common in adults with epilepsy, and screening should be a routine part of long-term follow-up.</p><p>The most common comorbidities and complications of epilepsy in adults are discussed here. An overview of the management of epilepsy is presented separately. (See  <a class="medical medical_review" href="/z/d/html/2220.html" rel="external">"Overview of the management of epilepsy in adults"</a>.)</p><p class="headingAnchor" id="H4167947718"><span class="h1">PSYCHOSOCIAL ISSUES</span><span class="headingEndMark"> — </span>Management of patients with epilepsy must include consideration of the psychosocial dimensions of the disorder [<a href="#rid1">1,2</a>]. In addition to medical and psychiatric comorbidities, patients with epilepsy suffer from loss of independence, underemployment, poorer social status, decreased leisure time, and decreased physical activity compared with unaffected adults [<a href="#rid3">3-6</a>].</p><p>Employment status is often negatively impacted by epilepsy, even when seizures are infrequent [<a href="#rid7">7-9</a>]. In one survey, more than 40 percent of college-educated people with seizures that were deemed well controlled were unemployed [<a href="#rid7">7</a>].</p><p>Newly diagnosed patients with epilepsy are commonly affected by the loss of independence that is most obvious in their inability to drive. They may also have problems obtaining insurance and finding or maintaining suitable employment. Their self-esteem may also suffer [<a href="#rid10">10</a>]. As the treatment plan is formulated, psychosocial issues must be systematically explored with patients so that appropriate referrals for additional help and counseling can be initiated.</p><p>Patients with epilepsy are more likely to have a poor pattern of health-related behaviors (eg, less physical activity and increased rates of smoking, alcohol consumption, and substance use disorders) compared with the general population [<a href="#rid11">11-15</a>]. Counseling regarding these issues may improve health and quality of life.</p><p>A complete psychosocial history includes inquiries about educational background, employment, driving, insurance, interpersonal relationships, previous psychiatric illness (especially depression), and attitude toward having epilepsy. Questionnaires for this purpose are available, and they provide a measurable way of assessing and following patients as pharmacotherapeutic and psychosocial interventions are implemented [<a href="#rid16">16</a>].</p><p>Identifying sources of psychosocial stress should lead to the development of strategies to minimize the impact of those stresses on the patient. Patients are often deeply concerned about health, independence, personal growth, relationships, well-being, and security; those with stress-induced seizures may be candidates for stress reduction, biofeedback, or relaxation training. Although direct evidence is limited, psychologic interventions may be of some benefit [<a href="#rid2">2,17-19</a>]. As an example, a randomized trial of 60 patients with drug-resistant epilepsy found that mindfulness-based therapy improved quality of life, depressive and anxiety symptoms, and seizure frequency compared with social support [<a href="#rid17">17</a>].</p><p>Many resources are available to help patients. In the absence of a local epilepsy group, patients should be encouraged to contact a regional or national epilepsy organization such as the Epilepsy Foundation (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.epilepsy.com%2F&amp;token=%2B0rEyHQ1T7gRoXXx698zApC%2B8iwIzFRJL%2FBkOdkUJ3O90fpR2jO2QiMSVmB3FZHJ&amp;TOPIC_ID=114559" target="_blank">https://www.epilepsy.com/</a>).</p><p class="headingAnchor" id="H810062849"><span class="h1">PSYCHIATRIC DISORDERS</span><span class="headingEndMark"> — </span>A variety of psychiatric disorders, in particular depression and anxiety, occur with increased frequency among people with epilepsy. Recognition and treatment of comorbid psychiatric disease is critical to holistic care of people with epilepsy.</p><p class="headingAnchor" id="H2879880059"><span class="h2">Depression and anxiety</span></p><p class="headingAnchor" id="H3174371098"><span class="h3">Prevalence and risk factors</span><span class="headingEndMark"> — </span>Mood disorders, particularly anxiety and depression, are common in patients with epilepsy [<a href="#rid5">5,11,20-25</a>]. The reported prevalence of depression in patients with epilepsy ranges from 13 to 35 percent, with much of the variability explained by differences in methods of ascertaining depression [<a href="#rid26">26</a>]. Rates are even higher among patients with uncontrolled epilepsy. In one community health survey, epilepsy was associated with 43 percent higher odds of depression after adjustment for other demographic factors [<a href="#rid21">21</a>]. Results from surveys in Canada and England have also reported higher odds of anxiety, depression, and suicidal ideation among those with epilepsy [<a href="#rid22">22,27</a>].</p><p>Risk factors for depression in people with epilepsy include epilepsy-related disability, unemployment and activity restriction, impaired social support, older age, female sex, low education level, anxiety, poor antiseizure medication adherence, and a perceived stigma associated with the diagnosis [<a href="#rid28">28,29</a>]. Other reports that find a high rate of psychiatric comorbidity (including depression, bipolar disease, psychosis, anxiety, and suicidality) predating seizure onset suggest a bidirectional relationship and perhaps a common underlying mechanism for psychiatric disorders and epilepsy [<a href="#rid30">30,31</a>].</p><p>Adverse effects of antiseizure medications and other medications should not be overlooked as a contributing factor to mood disorders. Antiseizure medications that may have negative effects on mood include <a class="drug drug_general" data-topicid="9763" href="/z/d/drug information/9763.html" rel="external">phenobarbital</a>, <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">topiramate</a>, <a class="drug drug_general" data-topicid="10144" href="/z/d/drug information/10144.html" rel="external">tiagabine</a>, <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">gabapentin</a>, <a class="drug drug_general" data-topicid="9904" href="/z/d/drug information/9904.html" rel="external">levetiracetam</a>, <a class="drug drug_general" data-topicid="8719" href="/z/d/drug information/8719.html" rel="external">clobazam</a>, <a class="drug drug_general" data-topicid="9862" href="/z/d/drug information/9862.html" rel="external">zonisamide</a>, and <a class="drug drug_general" data-topicid="87037" href="/z/d/drug information/87037.html" rel="external">perampanel</a> [<a href="#rid32">32</a>]. Polytherapy and a personal or family history of mood disorders or alcoholism are also risk factors for antiseizure medication-induced depression [<a href="#rid29">29,33</a>].</p><p>Mood disturbances are important contributors to decreased health-related quality of life [<a href="#rid20">20,34-38</a>]. One study suggested that the presence of a mood disorder also increases the likelihood of an antiseizure medication-related adverse event, which may, in turn, contribute to drug intolerance and nonadherence as well [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H1212533788"><span class="h3">Suicide risk</span><span class="headingEndMark"> — </span>Suicide risk is a particular concern in patients with epilepsy [<a href="#rid40">40,41</a>]. Suicidal ideation can occur as part of an interictal mood disorder or as postictal symptomatology [<a href="#rid33">33</a>].</p><p>A population-based study in Denmark demonstrated a three-fold higher risk for suicide in patients with epilepsy compared with controls [<a href="#rid42">42</a>]. Similar risk was demonstrated in a separate population-based study both in the three years before and after a diagnosis of epilepsy [<a href="#rid31">31</a>].</p><p>The risk of suicide is elevated in patients with and without known psychiatric comorbidity [<a href="#rid25">25,43-45</a>], although psychiatric comorbidities are underdiagnosed in patients with epilepsy. The risk is not fully explained by use of antiseizure medications, which have been associated with an increased risk of suicidality [<a href="#rid46">46</a>]. Additional risk factors may include male sex, temporal lobe epilepsy, and high seizure frequency [<a href="#rid44">44,45,47</a>]. (See  <a class="medical medical_review" href="/z/d/html/2220.html" rel="external">"Overview of the management of epilepsy in adults", section on 'Side effects of therapy'</a>.)</p><p class="headingAnchor" id="H3408943471"><span class="h3">Screening</span><span class="headingEndMark"> — </span>Given the high prevalence of mood disorders in epilepsy, patients should be screened as part of regular follow-up. International consensus group guidelines for the management of depression and other psychiatric conditions associated with epilepsy include the following recommendations [<a href="#rid2">2,48</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients should be screened for depression at diagnosis of epilepsy, prior to and following antiseizure medication initiation or changes, and at routine follow-up (eg, yearly). The Patient Health Questionnaire-9  (<a class="graphic graphic_table graphicRef59307" href="/z/d/graphic/59307.html" rel="external">table 1</a>) and Neurological Disorders Depression Inventory for Epilepsy are suggested tools. Both are publically available and have been validated in adults with epilepsy [<a href="#rid49">49,50</a>]. (See  <a class="medical medical_review" href="/z/d/html/14860.html" rel="external">"Using scales to monitor symptoms and treat depression (measurement based care)"</a> and  <a class="medical medical_review" href="/z/d/html/83887.html" rel="external">"Screening for depression in adults", section on 'Screening tests'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Because of the risk of suicide as well as the adverse impact of depression on quality of life and seizure control, patients who screen positive for depression should receive appropriate evaluation and treatment of depression rather than watchful waiting. This may be accomplished in collaboration with the primary care provider or through referral to a mental health clinician, depending on the severity of the psychiatric symptoms and comfort level of the treating clinician. (See  <a class="medical medical_review" href="/z/d/html/1721.html" rel="external">"Unipolar depression in adults: Assessment and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">"Unipolar major depression in adults: Choosing initial treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with epilepsy should be advised about the risk of suicide associated with epilepsy and antiseizure medication therapy. Although clinicians may worry at times that asking about suicide will prompt suicidal thoughts or actions, there are no data to support this concern, and patients may not verbalize suicidal feelings without being prompted. Patients with suicidal ideation should be referred for appropriate intervention. (See  <a class="medical medical_review" href="/z/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anxiety is a common comorbid condition in patients with epilepsy, and patients may benefit from specific treatment. The generalized anxiety disorder seven-item (GAD-7) scale  (<a class="graphic graphic_table graphicRef77755" href="/z/d/graphic/77755.html" rel="external">table 2</a>) is easy to administer and has been validated in people with epilepsy [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/z/d/html/496.html" rel="external">"Generalized anxiety disorder in adults: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/101879.html" rel="external">"Generalized anxiety disorder in adults: Management"</a>.)</p><p></p><p class="headingAnchor" id="H739439901"><span class="h3">Treatment considerations</span><span class="headingEndMark"> — </span>Mood-altering effects of antiseizure medications should not be overlooked in patients who have developed depression or anxiety in a temporal relationship to new or discontinued medications. Iatrogenic causes of worsening mood symptoms in people with epilepsy include:</p><p class="bulletIndent1"><span class="glyph">●</span>Discontinuation of a medication with mood-stabilizing effects (eg, <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">carbamazepine</a>, <a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">lamotrigine</a>, <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">valproate</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Withdrawal of medications with anxiolytic properties (eg, benzodiazepines, <a class="drug drug_general" data-topicid="9763" href="/z/d/drug information/9763.html" rel="external">phenobarbital</a>, <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">gabapentin</a>, <a class="drug drug_general" data-topicid="9473" href="/z/d/drug information/9473.html" rel="external">pregabalin</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Introduction or rapid dose increase of an antiseizure medication with negative psychotropic properties, such as <a class="drug drug_general" data-topicid="8719" href="/z/d/drug information/8719.html" rel="external">clobazam</a>, <a class="drug drug_general" data-topicid="9763" href="/z/d/drug information/9763.html" rel="external">phenobarbital</a>, <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">topiramate</a>, <a class="drug drug_general" data-topicid="10115" href="/z/d/drug information/10115.html" rel="external">vigabatrin</a>, <a class="drug drug_general" data-topicid="10144" href="/z/d/drug information/10144.html" rel="external">tiagabine</a>, <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">gabapentin</a>, <a class="drug drug_general" data-topicid="9904" href="/z/d/drug information/9904.html" rel="external">levetiracetam</a>, <a class="drug drug_general" data-topicid="9862" href="/z/d/drug information/9862.html" rel="external">zonisamide</a>, or <a class="drug drug_general" data-topicid="87037" href="/z/d/drug information/87037.html" rel="external">perampanel</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Addition of an enzyme-inducing antiseizure medication in a patient who is taking an antidepressant that is hepatically metabolized</p><p></p><p>Absent reversible factors such as medication side effects, people with epilepsy and depression or anxiety should be managed similarly to the general adult population. Barriers to effective depression treatment in people with epilepsy include lack of access to psychiatric care, reluctance to accept the diagnosis or take more medication, and prior experience with therapy that was seen as unhelpful [<a href="#rid33">33,52,53</a>].</p><p>A common misconception is that all antidepressants lower the seizure threshold and should be avoided; these fears are largely associated with overdose and have little merit when antidepressants are used in a therapeutic range [<a href="#rid32">32,54</a>]. Potential exceptions include <a class="drug drug_general" data-topicid="9171" href="/z/d/drug information/9171.html" rel="external">bupropion</a>, <a class="drug drug_general" data-topicid="9283" href="/z/d/drug information/9283.html" rel="external">clomipramine</a>, <a class="drug drug_general" data-topicid="8652" href="/z/d/drug information/8652.html" rel="external">amoxapine</a>, and <a class="drug drug_general" data-topicid="9588" href="/z/d/drug information/9588.html" rel="external">maprotiline</a> [<a href="#rid33">33</a>].</p><p>Selective serotonin reuptake inhibitors (SSRIs) and selective serotonin-norepinephrine reuptake inhibitors (SNRIs) such as <a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">venlafaxine</a> have at least some direct evidence of efficacy in people with epilepsy [<a href="#rid55">55,56</a>] and are good options because they are unlikely to worsen seizure frequency and have minimal interactions with most antiseizure medications. Some SSRIs and SNRIs and most tricyclic antidepressants have effects on cytochrome P450 (CYP) isozymes that can alter metabolism of some antiseizure medications; specific interactions may be determined by use of the <a class="external" href="/drug-interactions">drug interactions program</a> within UpToDate. Among the SSRIs, <a class="drug drug_general" data-topicid="8874" href="/z/d/drug information/8874.html" rel="external">citalopram</a> and <a class="drug drug_general" data-topicid="9046" href="/z/d/drug information/9046.html" rel="external">escitalopram</a> may have the fewest effects on the CYP system.</p><p>Psychotherapy for depression in patients with epilepsy is underutilized but has been shown to be effective in several randomized trials [<a href="#rid54">54,57</a>].</p><p>Epilepsy is not an absolute contraindication to electroconvulsive therapy (ECT), which has been used with success in small case series of patients with treatment-refractory depression and epilepsy [<a href="#rid58">58,59</a>]. The two major considerations in patients with epilepsy are the potentially higher risk for prolonged seizure and the impact of antiseizure medications on seizure threshold [<a href="#rid58">58</a>]. Patients with recent seizures or a history of status epilepticus should be closely monitored and maintained on antiseizure medications during ECT. Withholding a dose the night before or morning of ECT may be considered in patients without recent seizures if seizures are difficult to elicit during ECT. (See  <a class="medical medical_review" href="/z/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults"</a> and  <a class="medical medical_review" href="/z/d/html/4817.html" rel="external">"Medical evaluation for electroconvulsive therapy", section on 'Coexisting neurologic and neurosurgical disease'</a>.)</p><p>The treatment of depression and anxiety are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">"Unipolar major depression in adults: Choosing initial treatment"</a> and  <a class="medical medical_review" href="/z/d/html/101879.html" rel="external">"Generalized anxiety disorder in adults: Management"</a>.)</p><p class="headingAnchor" id="H2582169022"><span class="h2">Psychotic disorders</span><span class="headingEndMark"> — </span>The incidence of psychotic disorders is two- to threefold higher in patients with epilepsy compared with the general population [<a href="#rid27">27,60,61</a>], and the pooled prevalence rate of psychosis in patients with epilepsy is 5.6 percent [<a href="#rid62">62</a>]. In addition to comorbid primary psychiatric disorders such as schizophrenia, psychotic disorders may be related to epilepsy itself (ie, interictal psychosis, postictal psychosis) or secondary to antiseizure medications [<a href="#rid63">63,64</a>].</p><p>In a single-center review of over 2600 adults with epilepsy, the prevalence of psychotic disorders was 3.7 percent [<a href="#rid65">65</a>]. Among 98 patients with psychotic disorders, the most common diagnoses were interictal psychosis of epilepsy (34 percent), postictal psychosis (26 percent), comorbid schizophrenia/schizophreniform disorder (19 percent), and antiseizure medication-induced psychotic disorders (14 percent). <a class="drug drug_general" data-topicid="9904" href="/z/d/drug information/9904.html" rel="external">Levetiracetam</a> was the most commonly implicated antiseizure medication, temporally related to the onset of psychosis in 10 of 14 cases; other implicated drugs were <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">topiramate</a>, <a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">lamotrigine</a>, and withdrawal of <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">valproate</a>. Risk factors for drug-induced psychosis were female sex and temporal lobe involvement; concurrent treatment with <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">carbamazepine</a> appeared to be protective against development of psychosis.</p><p>Patients with temporal lobe epilepsy are at increased risk for postictal psychosis, accounting for approximately 75 percent of all cases [<a href="#rid66">66,67</a>]. They may also make up a disproportionate number of patients with interictal psychosis, although the relationship is weaker [<a href="#rid68">68</a>]. Postictal psychosis usually begins within 48 to 72 hours of a seizure or cluster of seizures, following a lucid interval. Postictal psychosis is often associated with positive symptoms including paranoid or referential delusions, hallucinations, and aggression, whereas interictal psychosis may be more likely to manifest with disorganization and negative symptoms [<a href="#rid66">66,69-71</a>]. An electroencephalogram (EEG) can be helpful to assess for ongoing subclinical seizures that may be contributing to symptoms.</p><p>Patients with epilepsy and psychosis should be managed similarly to other patients with psychotic disorders. Most patients with antiseizure medication-induced psychosis will improve with discontinuation of the offending drug, although some patients may require short-term treatment with an antipsychotic drug [<a href="#rid65">65</a>]. The initial evaluation and management of psychosis is reviewed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/17193.html" rel="external">"Psychosis in adults: Epidemiology, clinical manifestations, and diagnostic evaluation"</a>.)</p><p class="headingAnchor" id="H2903624493"><span class="h2">Psychogenic nonepileptic seizures</span><span class="headingEndMark"> — </span>Epilepsy and psychogenic nonepileptic seizures (PNES) are not mutually exclusive, and up to one-third of epilepsy patients treated at tertiary care epilepsy centers have both disorders [<a href="#rid72">72</a>]. Risk factors for PNES include female sex, comorbid psychiatric disorders (eg, posttraumatic stress disorder, depression, anxiety), a history of physical or sexual abuse, and psychosocial stress. (See  <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">"Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis", section on 'Common comorbidities'</a>.)</p><p>PNES should be considered in patients with previously well-controlled epilepsy who develop recurrent events, particularly when semiology differs from prior seizures, and in patients with apparently drug-resistant epilepsy who have atypical features for seizure by history (eg, asynchronous, variable, or waxing and waning motor activity; prolonged events with incomplete loss of consciousness; events always occurring in front of witnesses). (See  <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">"Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p>Video EEG is often required for diagnosis and captures a typical event in a large majority of patients with PNES within the first 48 hours of recording [<a href="#rid73">73,74</a>]. Ongoing neurologic follow-up is an important component of multidisciplinary care for patients with PNES, both because epileptic and nonepileptic seizures frequently co-occur and because mixed or conflicting communication among providers can contribute to the morbidity of the disorder. (See  <a class="medical medical_review" href="/z/d/html/131655.html" rel="external">"Psychogenic nonepileptic seizures: Management and prognosis", section on 'Follow-up'</a>.)</p><p class="headingAnchor" id="H996380764"><span class="h1">COGNITIVE IMPAIRMENT</span><span class="headingEndMark"> — </span>Cognitive problems are common in people with epilepsy [<a href="#rid48">48</a>]. Cognitive impairment is often present at the time of diagnosis, particularly when assessed by a comprehensive neuropsychologic test battery that can detect mild impairments in multiple domains, and may worsen over time [<a href="#rid75">75-77</a>]. A variety of factors contribute to cognitive dysfunction, including [<a href="#rid1">1,78-83</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Age</p><p class="bulletIndent1"><span class="glyph">●</span>Underlying epilepsy etiology and genetic variants</p><p class="bulletIndent1"><span class="glyph">●</span>Effects of frequent or prolonged seizures</p><p class="bulletIndent1"><span class="glyph">●</span>Comorbid psychiatric disorders (see <a class="local">'Screening'</a> above and <a class="local">'Treatment considerations'</a> above)</p><p class="bulletIndent1"><span class="glyph">●</span>Side effects of antiseizure medications and other medications</p><p class="bulletIndent1"><span class="glyph">●</span>Complications of other therapies, such as epilepsy surgery (see  <a class="medical medical_review" href="/z/d/html/91820.html" rel="external">"Surgical treatment of epilepsy in adults", section on 'Surgical complications'</a>)</p><p></p><p>Any antiseizure medication can impair cognition. In general, the severity can be influenced by titration rate, total daily dose or blood level, and the number of concomitant antiseizure medications. Patients may have variable susceptibility to cognitive side effects depending on their baseline level of function and comorbidities. Among the commonly used antiseizure medications, <a class="drug drug_general" data-topicid="9763" href="/z/d/drug information/9763.html" rel="external">phenobarbital</a>, benzodiazepines, <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">topiramate</a>, and <a class="drug drug_general" data-topicid="9862" href="/z/d/drug information/9862.html" rel="external">zonisamide</a> may be the most likely to cause adverse effects. Topiramate can induce specific problems with expressive language (word finding, speech fluency) as well as short-term memory problems, psychomotor slowing, and somnolence. <a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">Lamotrigine</a>, <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">gabapentin</a>, and <a class="drug drug_general" data-topicid="9904" href="/z/d/drug information/9904.html" rel="external">levetiracetam</a> are generally felt to have a low risk of cognitive side effects. (See  <a class="medical medical_review" href="/z/d/html/2221.html" rel="external">"Antiseizure medications: Mechanism of action, pharmacology, and adverse effects"</a>.)</p><p>Although it is commonly accepted that antiseizure medications can impair cognition, patients with epilepsy often have multiple other factors that have adverse cognitive effects. In this context, a prospective study of 331 patients admitted to an inpatient video EEG monitoring unit found that no prescribed antiseizure medication (including <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">topiramate</a> and <a class="drug drug_general" data-topicid="9862" href="/z/d/drug information/9862.html" rel="external">zonisamide</a>) was independently associated with cognitive dysfunction, suggesting that the risk for medication-induced cognitive changes should not be unduly emphasized [<a href="#rid83">83</a>].</p><p>The International League Against Epilepsy (ILAE) neuropsychology task force endorses routine screening of mental health and health-related quality of life in all patients with epilepsy [<a href="#rid2">2,84</a>]. Routine screening can take the form of self-report questionnaires, computerized assessment batteries, and/or clinical questioning of mood, psychologic adjustment, and subjective cognitive complaints (eg, attention, memory, or word-finding difficulties).</p><p>Formal neuropsychologic assessment and cognitive rehabilitation, although understudied, may be helpful for some patients with cognitive complaints [<a href="#rid48">48,85</a>]. Small studies support the role of cognitive rehabilitation to improve memory after temporal lobe epilepsy surgery [<a href="#rid86">86,87</a>]. Small studies suggest that <a class="drug drug_general" data-topicid="9638" href="/z/d/drug information/9638.html" rel="external">methylphenidate</a> is safe in adults with epilepsy and may lead to short-term improvements in memory, attention, and quality of life, even in the absence of premorbid attention deficit hyperactivity disorder [<a href="#rid88">88,89</a>].</p><p class="headingAnchor" id="H2641214560"><span class="h1">SLEEP DISORDERS</span><span class="headingEndMark"> — </span>Comorbid sleep disorders are common in patients with epilepsy, especially those with medically refractory seizures [<a href="#rid90">90-95</a>]. Comorbid sleep disorders are important to recognize and treat, as sleep disruption may contribute to poor seizure control and decreased quality of life. The three most common disorders are sleep-disordered breathing, restless legs syndrome/Willis-Ekbom disease (RLS/WED), and insomnia [<a href="#rid90">90-94,96</a>].</p><p class="headingAnchor" id="H1820004735"><span class="h2">Obstructive sleep apnea</span><span class="headingEndMark"> — </span>Obstructive sleep apnea (OSA) is present in approximately 20 to 40 percent of adults with medically refractory epilepsy, and comorbid OSA has been associated with worsened seizure frequency [<a href="#rid90">90-94</a>].</p><p>Polysomnography is indicated in patients who report daytime sleepiness or other symptoms of OSA (eg, loud snoring, waking up gasping or choking, witnessed pauses in breathing during sleep). Small studies suggest that screening instruments or home portable oximetry may be useful to better identify OSA in patients who do not report daytime sleepiness or snoring [<a href="#rid97">97</a>]. (See  <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults"</a>.)</p><p>Continuous positive airway pressure (CPAP) therapy is the mainstay of treatment for OSA in adults. Several observational studies in patients with epilepsy and comorbid OSA have found that CPAP use is associated with a reduction in both seizures and interictal epileptiform discharges, as well as improvement in subjective sleepiness, with 50 to 60 percent of patients achieving ≥50 percent reduction in seizure frequency [<a href="#rid98">98-101</a>]. (See  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults"</a>.)</p><p class="headingAnchor" id="H3932452127"><span class="h2">Insomnia and other sleep disturbances</span><span class="headingEndMark"> — </span>Insomnia is reported by more than half of patients with epilepsy and may be more severe among those with comorbid depression and medical illness [<a href="#rid102">102</a>]. Symptoms of RLS/WED may contribute to problems with sleep initiation and should prompt measurement of iron stores and consideration of pharmacologic therapy with either a dopamine agonist or an alpha-2-delta calcium channel ligand. (See  <a class="medical medical_review" href="/z/d/html/7684.html" rel="external">"Risk factors, comorbidities, and consequences of insomnia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">"Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults"</a> and  <a class="medical medical_review" href="/z/d/html/88241.html" rel="external">"Management of restless legs syndrome and periodic limb movement disorder in adults"</a>.)</p><p class="headingAnchor" id="H2001010710"><span class="h1">CARDIOVASCULAR DISEASE</span><span class="headingEndMark"> — </span>Adults with epilepsy have increased rates of medical comorbidities that can complicate epilepsy management, contribute to decreased health-related quality of life, increase health care costs, and shorten lifespan [<a href="#rid4">4,103-106</a>]. These associations might result from a variety of factors, including shared risk factors, treatment side effects (eg, weight gain, altered lipid profiles), or shared genetic, environmental, or other factors [<a href="#rid103">103,105</a>].</p><p>In an analysis of data from the United States National Health Interview Survey, adults with epilepsy had an increased prevalence of cardiovascular, respiratory, inflammatory, and pain disorders compared with adults without epilepsy [<a href="#rid105">105</a>]. This included increased rates of self-reported heart disease (18 versus 11 percent), high blood pressure (34 versus 29 percent), stroke (14 versus 2 percent), and obesity (34 versus 28 percent). A large database study in Hong Kong found similar results and identified enzyme-inducing antiseizure medications as an independent risk factor for incident physical comorbidities, especially cerebrovascular disease [<a href="#rid107">107</a>]. Observational data suggest that enzyme-inducing antiseizure medications (eg, <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">carbamazepine</a>, <a class="drug drug_general" data-topicid="9769" href="/z/d/drug information/9769.html" rel="external">phenytoin</a>) may contribute to hyperlipidemia and thereby worsen comorbid cardiovascular disease [<a href="#rid108">108,109</a>].</p><p>There is also evidence that most episodes of cardiac arrest in people with epilepsy are not temporally related to a typical seizure [<a href="#rid110">110</a>], distinguishing them from sudden unexpected death in epilepsy (SUDEP), which is thought to occur in the context of a seizure. Several studies have shown that people with epilepsy have a nearly three-fold higher risk of sudden cardiac death compared with the general population, and a 4.5-fold higher risk of sudden cardiac death compared with the risk of SUDEP [<a href="#rid111">111-113</a>]. One explanation for these findings is that chronic epilepsy may trigger repetitive episodes of catecholamine surges, hypoxemia, and myocardial ischemic that cause electrical and mechanical cardiac dysfunction [<a href="#rid114">114</a>]. These data suggest that patients with epilepsy should be monitored with electrocardiography at baseline and during treatment [<a href="#rid113">113</a>].</p><p>Recognition of medical comorbidities can facilitate treatment of epilepsy and is particularly important when selecting antiseizure medication therapy. (See  <a class="medical medical_review" href="/z/d/html/2212.html" rel="external">"Initial treatment of epilepsy in adults", section on 'Comorbid medical conditions'</a>.)</p><p class="headingAnchor" id="H2139757855"><span class="h1">BONE DISEASE</span><span class="headingEndMark"> — </span>People with epilepsy are at increased risk for decreased bone mineral density, abnormal vitamin D metabolism, and fractures related to long-term treatment with antiseizure medications. These effects are most commonly associated with antiseizure medications that induce the cytochrome P450 (CYP) enzyme system (eg, <a class="drug drug_general" data-topicid="9763" href="/z/d/drug information/9763.html" rel="external">phenobarbital</a>, <a class="drug drug_general" data-topicid="9769" href="/z/d/drug information/9769.html" rel="external">phenytoin</a>, <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">carbamazepine</a>, <a class="drug drug_general" data-topicid="9467" href="/z/d/drug information/9467.html" rel="external">oxcarbazepine</a>) but have also been described in association with <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">valproate</a>, <a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">lamotrigine</a>, and polytherapy. Screening and prevention of bone disease in people with epilepsy is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/2063.html" rel="external">"Antiseizure medications and bone disease", section on 'Screening'</a> and  <a class="medical medical_review" href="/z/d/html/2063.html" rel="external">"Antiseizure medications and bone disease", section on 'Treatment and prevention'</a>.)</p><p class="headingAnchor" id="H1102849596"><span class="h1">ACCIDENTS AND INJURIES</span><span class="headingEndMark"> — </span>Several studies have demonstrated that the risk of seizure-related personal injury, such as falls, bone fractures, drowning, and other accidents, is significantly elevated compared with control subjects [<a href="#rid115">115-121</a>]. However, most of these studies selected preferentially for patients with injuries or more severe seizures, as most subjects were evaluated in emergency departments or tertiary centers [<a href="#rid122">122</a>].</p><p>A population-based study in Europe found that seizure-related accidents occurred in only 6.5 percent of the cohort at two years of follow-up; risk was largely determined by higher seizure frequency [<a href="#rid123">123</a>]. Similarly, a subsequent population-based study in the United States found that the risk of seizure-related injury was low and that most injuries were minor and without adverse social or occupational consequences [<a href="#rid122">122</a>]. Seizure frequency was the only significant risk factor for seizure-related injury.</p><p>Patients with poorly controlled seizures are at the highest risk for seizure-related injury. However, for most patients with epilepsy, excessive restriction of activities for the purpose of avoiding injury is unnecessary [<a href="#rid122">122</a>]. Supervision of swimming is a reasonable precaution.</p><p>The relative risk of a motor vehicle crash in a person with epilepsy compared with other drivers has been variously estimated and may be as high as 2.0. The seizure-free interval (time since last seizure) is believed to be an important factor in assessing the risk of a crash. (See  <a class="medical medical_review" href="/z/d/html/2226.html" rel="external">"Driving restrictions for patients with seizures and epilepsy"</a>.)</p><p>A few studies have suggested that people with epilepsy may be at higher risk of violent assault. In one report, the relative risk of death from homicide in the home was more than twofold higher in patients with epilepsy compared with controls [<a href="#rid124">124</a>]. One population-based study in Canada found that individuals with epilepsy were more likely to suffer assault-related injuries compared with normal controls [<a href="#rid43">43</a>].</p><p>It is recommended that clinicians regularly review relevant safety issues with their patients with epilepsy [<a href="#rid125">125</a>].</p><p class="headingAnchor" id="H1041791657"><span class="h1">PREMATURE MORTALITY</span><span class="headingEndMark"> — </span>People with epilepsy are at substantially increased risk for premature mortality compared with the general population. Across all age groups, standardized mortality ratios (SMRs) range from two to three, indicating that the observed numbers of deaths in people with epilepsy are two- to threefold higher than in reference populations without epilepsy [<a href="#rid126">126-128</a>]. SMRs are substantially higher in children compared with adults and among those with structural/metabolic etiologies, medically refractory epilepsy, and convulsive seizures. In studies that have examined SMRs as a function of time since diagnosis, risk is highest in the first several years after diagnosis and then decreases, although does not normalize, with passage of time [<a href="#rid129">129-131</a>].</p><p>Even a single unprovoked seizure (an idiopathic seizure or a seizure that occurs in relation to a preexisting brain lesion or progressive nervous system disorder) is associated with increased mortality. A prospective study, with a mean follow-up of approximately seven years, found a threefold increase in mortality for patients with a first-ever unprovoked seizure (n = 1276) compared with matched controls (n = 2556); the increased mortality was largely related to the underlying cause of the seizures, being independent of seizure recurrence [<a href="#rid132">132</a>].</p><p>Comorbid brain disorders contribute to excess mortality, particularly in children. SMRs range from 11 to 50 in patients with disorders characterized as static or progressive encephalopathies; major congenital and acquired central nervous system disorders including cerebral palsy, intellectual disability, and tumors; and degenerative dementias [<a href="#rid126">126</a>]. More modest increases in the SMR (up to 2.1) have been observed in patients with idiopathic or cryptogenic etiologies.</p><p>Important causes of death directly attributable to epilepsy include sudden unexpected death in epilepsy (SUDEP), status epilepticus, unintentional injuries, and suicide. Among these, accidental death may be the largest contributor to excess mortality [<a href="#rid133">133</a>]. In observational studies, accidental death rates in people with epilepsy are approximately threefold higher compared with people without epilepsy [<a href="#rid133">133-135</a>]. The risk of a drowning death, in particular, is higher in patients with epilepsy, with an estimated relative risk ranging from 13- to 19-fold [<a href="#rid119">119,134,135</a>].</p><p>Psychiatric comorbidity is another important contributing factor. In a population-based cohort study in Sweden, the premature death rate in patients with epilepsy was 9 percent, compared with 0.7 percent in the general population [<a href="#rid136">136</a>]. External causes (eg, accidents, poisonings, suicide, assaults) accounted for 16 percent of epilepsy deaths, approximately half of which were from suicide. Among those who died from external causes, 75 percent had comorbid psychiatric disorders, and comorbid depression and substance misuse were the strongest risk factors for death (adjusted odds ratios 13 and 22, respectively).</p><p>In addition to deaths from external causes such as accidents or suicide, deaths attributed to other causes (eg, respiratory disorders, cancer, cerebrovascular disease) may also be higher in patients with chronic epilepsy [<a href="#rid107">107,137-139</a>]. One database study found that patients with epilepsy had high rates of comorbid illness, including pulmonary disease, hypertension, cerebrovascular disease, depression, and alcohol abuse [<a href="#rid11">11</a>]. A comorbidity index score predicted the risk of mortality.</p><p>Patients with epilepsy have a small risk of SUDEP [<a href="#rid140">140</a>]. Risk factors for SUDEP include early age of epilepsy onset, frequent generalized tonic-clonic seizures, and intractable epilepsy [<a href="#rid140">140-143</a>]. SUDEP is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/2215.html" rel="external">"Sudden unexpected death in epilepsy"</a>.)</p><p class="headingAnchor" id="H3355824209"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113971.html" rel="external">"Society guideline links: Seizures and epilepsy in adults"</a>.)</p><p class="headingAnchor" id="H3118472217"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>People with epilepsy suffer from loss of independence, underemployment, decreased leisure time, decreased physical activity, and increased substance use compared with unaffected adults, all of which can adversely impact quality of life. (See <a class="local">'Psychosocial issues'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Depression, anxiety, and suicidality are more common in patients with epilepsy than in the general population and should be assessed as part of routine follow-up. Mood-altering side effects of antiseizure medications should not be overlooked as a contributing factor in patients with emergent depression or suicidality. (See <a class="local">'Depression and anxiety'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cognitive impairment is often present at the time of diagnosis and may worsen over time. Contributing factors include underlying epilepsy etiology, side effects of medications and other epilepsy therapies, frequent or prolonged seizures, and comorbid mood disorders. (See <a class="local">'Cognitive impairment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sleep disorders, especially obstructive sleep apnea (OSA) and insomnia, are common in people with epilepsy and may contribute to worsened seizure control and quality of life. Polysomnography is indicated in patients who report daytime sleepiness or other symptoms of OSA (eg, loud snoring, waking up gasping or choking, witnessed pauses in breathing during sleep). (See <a class="local">'Sleep disorders'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adults with epilepsy have increased rates of medical comorbidities including heart disease, hypertension, stroke, obesity, and metabolic bone disease. (See <a class="local">'Cardiovascular disease'</a> above and <a class="local">'Bone disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>People with epilepsy are at substantially increased risk for premature mortality compared with the general population. Important causes of death directly attributable to epilepsy include sudden unexpected death in epilepsy (SUDEP), status epilepticus, unintentional injuries, and suicide. (See <a class="local">'Accidents and injuries'</a> above and <a class="local">'Premature mortality'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lin JJ, Mula M, Hermann BP. Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet 2012; 380:1180.</a></li><li><a class="nounderline abstract_t">Michaelis R, Tang V, Goldstein LH, et al. Psychological treatments for adults and children with epilepsy: Evidence-based recommendations by the International League Against Epilepsy Psychology Task Force. Epilepsia 2018; 59:1282.</a></li><li><a class="nounderline abstract_t">Strine TW, Kobau R, Chapman DP, et al. Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey. Epilepsia 2005; 46:1133.</a></li><li><a class="nounderline abstract_t">Gaitatzis A, Sisodiya SM, Sander JW. The somatic comorbidity of epilepsy: a weighty but often unrecognized burden. Epilepsia 2012; 53:1282.</a></li><li><a class="nounderline abstract_t">Gesche J, Antonson S, Dreier JW, et al. Social outcome and psychiatric comorbidity of generalized epilepsies - A case-control study. Epilepsia 2021; 62:1158.</a></li><li><a class="nounderline abstract_t">Willems LM, Zöllner JP, Hamann L, et al. Unemployment and early retirement among patients with epilepsy - A study on predictors, resilience factors and occupational reintegration measures. Epilepsy Behav 2023; 144:109255.</a></li><li><a class="nounderline abstract_t">Schachter SC, Shafer PO, Murphy W. The personal impact of epilepsy: Correlations with seizure frequency, employment, cost of medical care, and satisfaction with physician care. J Epilepsy 1993; 6:224.</a></li><li><a class="nounderline abstract_t">Holland P, Lane S, Whitehead M, et al. Labor market participation following onset of seizures and early epilepsy: Findings from a UK cohort. Epilepsia 2009; 50:1030.</a></li><li><a class="nounderline abstract_t">Jennum P, Gyllenborg J, Kjellberg J. The social and economic consequences of epilepsy: a controlled national study. Epilepsia 2011; 52:949.</a></li><li><a class="nounderline abstract_t">Gauffin H, Landtblom AM, Räty L. Self-esteem and sense of coherence in young people with uncomplicated epilepsy: a 5-year follow-up. Epilepsy Behav 2010; 17:520.</a></li><li><a class="nounderline abstract_t">St Germaine-Smith C, Liu M, Quan H, et al. Development of an epilepsy-specific risk adjustment comorbidity index. Epilepsia 2011; 52:2161.</a></li><li><a class="nounderline abstract_t">Hinnell C, Williams J, Metcalfe A, et al. Health status and health-related behaviors in epilepsy compared to other chronic conditions--a national population-based study. Epilepsia 2010; 51:853.</a></li><li><a class="nounderline abstract_t">Samokhvalov AV, Irving H, Mohapatra S, Rehm J. Alcohol consumption, unprovoked seizures, and epilepsy: a systematic review and meta-analysis. Epilepsia 2010; 51:1177.</a></li><li><a class="nounderline abstract_t">McIntosh AM, Carney PW, Tan KM, et al. Comorbidities in newly diagnosed epilepsy: Pre-existing health conditions are common and complex across age groups. Epilepsy Behav 2023; 138:108960.</a></li><li><a class="nounderline abstract_t">Jones SK, Korte JE, Wilson D. Hazard of substance abuse onset among adults diagnosed with epilepsy or migraine. Epilepsy Behav 2023; 144:109258.</a></li><li><a class="nounderline abstract_t">Devinsky O. Clinical uses of the quality-of-life in epilepsy inventory. Epilepsia 1993; 34 Suppl 4:S39.</a></li><li><a class="nounderline abstract_t">Tang V, Poon WS, Kwan P. Mindfulness-based therapy for drug-resistant epilepsy: An assessor-blinded randomized trial. Neurology 2015; 85:1100.</a></li><li><a class="nounderline abstract_t">Jackson CF, Makin SM, Baker GA. Neuropsychological and psychological interventions for people with newly diagnosed epilepsy. Cochrane Database Syst Rev 2015; :CD011311.</a></li><li><a class="nounderline abstract_t">Michaelis R, Tang V, Wagner JL, et al. Psychological treatments for people with epilepsy. Cochrane Database Syst Rev 2017; 10:CD012081.</a></li><li><a class="nounderline abstract_t">Layne Moore J, Elliott JO, Lu B, et al. Serious psychological distress among persons with epilepsy based on the 2005 California Health Interview Survey. Epilepsia 2009; 50:1077.</a></li><li><a class="nounderline abstract_t">Fuller-Thomson E, Brennenstuhl S. The association between depression and epilepsy in a nationally representative sample. Epilepsia 2009; 50:1051.</a></li><li><a class="nounderline abstract_t">Tellez-Zenteno JF, Patten SB, Jetté N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007; 48:2336.</a></li><li><a class="nounderline abstract_t">Kim M, Kim YS, Kim DH, et al. Major depressive disorder in epilepsy clinics: A meta-analysis. Epilepsy Behav 2018; 84:56.</a></li><li><a class="nounderline abstract_t">Goel P, Singh G, Bansal V, et al. Psychiatric comorbidities among people with epilepsy: A population-based assessment in disadvantaged communities. Epilepsy Behav 2022; 137:108965.</a></li><li><a class="nounderline abstract_t">Kanner AM, Saporta AS, Kim DH, et al. Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity. Neurology 2023; 100:e1123.</a></li><li><a class="nounderline abstract_t">Fiest KM, Dykeman J, Patten SB, et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology 2013; 80:590.</a></li><li><a class="nounderline abstract_t">Rai D, Kerr MP, McManus S, et al. Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia 2012; 53:1095.</a></li><li><a class="nounderline abstract_t">Reisinger EL, DiIorio C. Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months. Epilepsy Behav 2009; 15:196.</a></li><li><a class="nounderline abstract_t">Yang Y, Yang M, Shi Q, et al. Risk factors for depression in patients with epilepsy: A meta-analysis. Epilepsy Behav 2020; 106:107030.</a></li><li><a class="nounderline abstract_t">Adelöw C, Andersson T, Ahlbom A, Tomson T. Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology 2012; 78:396.</a></li><li><a class="nounderline abstract_t">Hesdorffer DC, Ishihara L, Mynepalli L, et al. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 2012; 72:184.</a></li><li><a class="nounderline abstract_t">Sirven JI. Management of Epilepsy Comorbidities. Continuum (Minneap Minn) 2016; 22:191.</a></li><li><a class="nounderline abstract_t">Barry JJ, Ettinger AB, Friel P, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008; 13 Suppl 1:S1.</a></li><li><a class="nounderline abstract_t">Szaflarski M, Meckler JM, Privitera MD, Szaflarski JP. Quality of life in medication-resistant epilepsy: the effects of patient's age, age at seizure onset, and disease duration. Epilepsy Behav 2006; 8:547.</a></li><li><a class="nounderline abstract_t">Kwan P, Yu E, Leung H, et al. Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy. Epilepsia 2009; 50:1059.</a></li><li><a class="nounderline abstract_t">Park SP, Song HS, Hwang YH, et al. Differential effects of seizure control and affective symptoms on quality of life in people with epilepsy. Epilepsy Behav 2010; 18:455.</a></li><li><a class="nounderline abstract_t">Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia 2011; 52:2168.</a></li><li><a class="nounderline abstract_t">Salpekar JA, Mula M. Common psychiatric comorbidities in epilepsy: How big of a problem is it? Epilepsy Behav 2019; 98:293.</a></li><li><a class="nounderline abstract_t">Kanner AM, Barry JJ, Gilliam F, et al. Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events? Epilepsia 2012; 53:1104.</a></li><li><a class="nounderline abstract_t">Stefanello S, Marín-Léon L, Fernandes PT, et al. Suicidal thoughts in epilepsy: a community-based study in Brazil. Epilepsy Behav 2010; 17:483.</a></li><li><a class="nounderline abstract_t">Hesdorffer DC, French JA, Posner K, et al. Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. Epilepsia 2013; 54:879.</a></li><li><a class="nounderline abstract_t">Christensen J, Vestergaard M, Mortensen PB, et al. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007; 6:693.</a></li><li><a class="nounderline abstract_t">Kwon C, Liu M, Quan H, et al. Motor vehicle accidents, suicides, and assaults in epilepsy: a population-based study. Neurology 2011; 76:801.</a></li><li><a class="nounderline abstract_t">Hesdorffer DC, Ishihara L, Webb DJ, et al. Occurrence and Recurrence of Attempted Suicide Among People With Epilepsy. JAMA Psychiatry 2016; 73:80.</a></li><li><a class="nounderline abstract_t">Schommer L, Streltzov N, Andrew A, Bujarski K. Factors associated with suicidal ideation in an epilepsy center in Northern New England. Epilepsy Behav 2021; 121:108009.</a></li><li class="breakAll">US Department of Health and Human Services. Statistical review and evaluation: Antiepileptic drugs and suicidality. Available at: https://www.fda.gov/files/drugs/published/Statistical-Review-and-Evaluation--Antiepileptic-Drugs-and-Suicidality.pdf (Accessed on August 08, 2021).</li><li><a class="nounderline abstract_t">Park SJ, Lee HB, Ahn MH, et al. Identifying clinical correlates for suicide among epilepsy patients in South Korea: A case-control study. Epilepsia 2015; 56:1966.</a></li><li><a class="nounderline abstract_t">Kerr MP, Mensah S, Besag F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011; 52:2133.</a></li><li><a class="nounderline abstract_t">Rathore JS, Jehi LE, Fan Y, et al. Validation of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adults with epilepsy. Epilepsy Behav 2014; 37:215.</a></li><li><a class="nounderline abstract_t">Gill SJ, Lukmanji S, Fiest KM, et al. Depression screening tools in persons with epilepsy: A systematic review of validated tools. Epilepsia 2017; 58:695.</a></li><li><a class="nounderline abstract_t">Micoulaud-Franchi JA, Lagarde S, Barkate G, et al. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample. Epilepsy Behav 2016; 57:211.</a></li><li><a class="nounderline abstract_t">Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54:573.</a></li><li><a class="nounderline abstract_t">Bermeo-Ovalle A. Psychiatric comorbidities go untreated in patients with epilepsy: Ignorance or denial? Epilepsy Behav 2019; 98:306.</a></li><li><a class="nounderline abstract_t">Elger CE, Johnston SA, Hoppe C. Diagnosing and treating depression in epilepsy. Seizure 2017; 44:184.</a></li><li><a class="nounderline abstract_t">Maguire MJ, Marson AG, Nevitt SJ. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev 2021; 4:CD010682.</a></li><li><a class="nounderline abstract_t">Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia 2022; 63:316.</a></li><li><a class="nounderline abstract_t">Li D, Song Y, Zhang S, et al. Cognitive behavior therapy for depression in people with epilepsy: A systematic review and meta-analysis. Epilepsy Behav 2023; 138:109056.</a></li><li><a class="nounderline abstract_t">Ducharme S, Murray ED, Seiner SJ, et al. Retrospective Analysis of the Short-Term Safety of ECT in Patients With Neurological Comorbidities: A Guide for Pre-ECT Neurological Evaluations. J Neuropsychiatry Clin Neurosci 2015; 27:311.</a></li><li><a class="nounderline abstract_t">Lunde ME, Lee EK, Rasmussen KG. Electroconvulsive therapy in patients with epilepsy. Epilepsy Behav 2006; 9:355.</a></li><li><a class="nounderline abstract_t">Qin P, Xu H, Laursen TM, et al. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ 2005; 331:23.</a></li><li><a class="nounderline abstract_t">Clarke MC, Tanskanen A, Huttunen MO, et al. Evidence for shared susceptibility to epilepsy and psychosis: a population-based family study. Biol Psychiatry 2012; 71:836.</a></li><li><a class="nounderline abstract_t">Clancy MJ, Clarke MC, Connor DJ, et al. The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry 2014; 14:75.</a></li><li><a class="nounderline abstract_t">Krishnamoorthy ES, Trimble MR, Blumer D. The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav 2007; 10:349.</a></li><li><a class="nounderline abstract_t">Braatz V, Martins Custodio H, Leu C, et al. Postictal Psychosis in Epilepsy: A Clinicogenetic Study. Ann Neurol 2021; 90:464.</a></li><li><a class="nounderline abstract_t">Chen Z, Lusicic A, O'Brien TJ, et al. Psychotic disorders induced by antiepileptic drugs in people with epilepsy. Brain 2016; 139:2668.</a></li><li><a class="nounderline abstract_t">Hilger E, Zimprich F, Pataraia E, et al. Psychoses in epilepsy: A comparison of postictal and interictal psychoses. Epilepsy Behav 2016; 60:58.</a></li><li><a class="nounderline abstract_t">Adachi N, Matsuura M, Okubo Y, et al. Predictive variables of interictal psychosis in epilepsy. Neurology 2000; 55:1310.</a></li><li><a class="nounderline abstract_t">Adachi N, Onuma T, Hara T, et al. Frequency and age-related variables in interictal psychoses in localization-related epilepsies. Epilepsy Res 2002; 48:25.</a></li><li><a class="nounderline abstract_t">Trimble M, Kanner A, Schmitz B. Postictal psychosis. Epilepsy Behav 2010; 19:159.</a></li><li><a class="nounderline abstract_t">Hilger E, Zimprich F, Jung R, et al. Postictal psychosis in temporal lobe epilepsy: a case-control study. Eur J Neurol 2013; 20:955.</a></li><li><a class="nounderline abstract_t">Tadokoro Y, Oshima T, Kanemoto K. Interictal psychoses in comparison with schizophrenia--a prospective study. Epilepsia 2007; 48:2345.</a></li><li><a class="nounderline abstract_t">Rudzinski LA, Meador KJ. Epilepsy and neuropsychological comorbidities. Continuum (Minneap Minn) 2013; 19:682.</a></li><li><a class="nounderline abstract_t">Woollacott IO, Scott C, Fish DR, et al. When do psychogenic nonepileptic seizures occur on a video/EEG telemetry unit? Epilepsy Behav 2010; 17:228.</a></li><li><a class="nounderline abstract_t">Perrin MW, Sahoo SK, Goodkin HP. Latency to first psychogenic nonepileptic seizure upon admission to inpatient EEG monitoring: evidence for semiological differences. Epilepsy Behav 2010; 19:32.</a></li><li><a class="nounderline abstract_t">Taylor J, Kolamunnage-Dona R, Marson AG, et al. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment? Epilepsia 2010; 51:48.</a></li><li><a class="nounderline abstract_t">Hermann BP, Seidenberg M, Dow C, et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol 2006; 60:80.</a></li><li><a class="nounderline abstract_t">Baker GA, Taylor J, Aldenkamp AP, SANAD group. Newly diagnosed epilepsy: cognitive outcome after 12 months. Epilepsia 2011; 52:1084.</a></li><li><a class="nounderline abstract_t">Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001; 357:216.</a></li><li><a class="nounderline abstract_t">Meador KJ. Cognitive outcomes and predictive factors in epilepsy. Neurology 2002; 58:S21.</a></li><li><a class="nounderline abstract_t">Aldenkamp AP, Bodde N. Behaviour, cognition and epilepsy. Acta Neurol Scand Suppl 2005; 182:19.</a></li><li><a class="nounderline abstract_t">Zhu L, Chen L, Xu P, et al. Genetic and molecular basis of epilepsy-related cognitive dysfunction. Epilepsy Behav 2020; 104:106848.</a></li><li><a class="nounderline abstract_t">Quon RJ, Mazanec MT, Schmidt SS, et al. Antiepileptic drug effects on subjective and objective cognition. Epilepsy Behav 2020; 104:106906.</a></li><li><a class="nounderline abstract_t">Foster E, Malpas CB, Ye K, et al. Antiepileptic drugs are not independently associated with cognitive dysfunction. Neurology 2020; 94:e1051.</a></li><li><a class="nounderline abstract_t">Wilson SJ, Baxendale S, Barr W, et al. Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017. Epilepsia 2015; 56:674.</a></li><li><a class="nounderline abstract_t">Del Felice A, Alderighi M, Martinato M, et al. Memory Rehabilitation Strategies in Nonsurgical Temporal Lobe Epilepsy: A Review. Am J Phys Med Rehabil 2017; 96:506.</a></li><li><a class="nounderline abstract_t">Geraldi CV, Escorsi-Rosset S, Thompson P, et al. Potential role of a cognitive rehabilitation program following left temporal lobe epilepsy surgery. Arq Neuropsiquiatr 2017; 75:359.</a></li><li><a class="nounderline abstract_t">Helmstaedter C, Loer B, Wohlfahrt R, et al. The effects of cognitive rehabilitation on memory outcome after temporal lobe epilepsy surgery. Epilepsy Behav 2008; 12:402.</a></li><li><a class="nounderline abstract_t">Adams J, Alipio-Jocson V, Inoyama K, et al. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial. Epilepsia 2017; 58:2124.</a></li><li><a class="nounderline abstract_t">van der Feltz-Cornelis CM, Aldenkamp AP. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial. Epilepsy Behav 2006; 8:659.</a></li><li><a class="nounderline abstract_t">Bassetti CL, Gugger M. Sleep disordered breathing in neurologic disorders. Swiss Med Wkly 2002; 132:109.</a></li><li><a class="nounderline abstract_t">Vaughn BV, D'Cruz OF. Obstructive sleep apnea in epilepsy. Clin Chest Med 2003; 24:239.</a></li><li><a class="nounderline abstract_t">Malow BA, Levy K, Maturen K, Bowes R. Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology 2000; 55:1002.</a></li><li><a class="nounderline abstract_t">Chihorek AM, Abou-Khalil B, Malow BA. Obstructive sleep apnea is associated with seizure occurrence in older adults with epilepsy. Neurology 2007; 69:1823.</a></li><li><a class="nounderline abstract_t">Berth W, St. Louis EK, Zimmerman MB, et al. Predictors of co-morbid obstructive sleep apnea in epilepsy. Neurology 2011; 76 (Suppl 4):A337.</a></li><li><a class="nounderline abstract_t">Tian N, Wheaton AG, Zack M, et al. Sleep duration and quality among U.S. adults with epilepsy: National Health Interview Survey 2013, 2015, and 2017. Epilepsy Behav 2021; 122:108194.</a></li><li><a class="nounderline abstract_t">Vendrame M, Jackson S, Syed S, et al. Central sleep apnea and complex sleep apnea in patients with epilepsy. Sleep Breath 2014; 18:119.</a></li><li><a class="nounderline abstract_t">Economou NT, Dikeos D, Andrews N, Foldvary-Schaefer N. Use of the Sleep Apnea Scale of the Sleep Disorders Questionnaire (SA-SDQ) in adults with epilepsy. Epilepsy Behav 2014; 31:123.</a></li><li><a class="nounderline abstract_t">Pornsriniyom D, Shinlapawittayatorn K, Fong J, et al. Continuous positive airway pressure therapy for obstructive sleep apnea reduces interictal epileptiform discharges in adults with epilepsy. Epilepsy Behav 2014; 37:171.</a></li><li><a class="nounderline abstract_t">Malow BA, Foldvary-Schaefer N, Vaughn BV, et al. Treating obstructive sleep apnea in adults with epilepsy: a randomized pilot trial. Neurology 2008; 71:572.</a></li><li><a class="nounderline abstract_t">Vendrame M, Auerbach S, Loddenkemper T, et al. Effect of continuous positive airway pressure treatment on seizure control in patients with obstructive sleep apnea and epilepsy. Epilepsia 2011; 52:e168.</a></li><li><a class="nounderline abstract_t">St. Louis EK, Berth W, Granner MA, et al. Seizure reduction following nasal continuous positive airway pressure therapy for co-morbid obstructive sleep apnea in epilepsy. Neurology 2011; 76(Suppl 4):A453.</a></li><li><a class="nounderline abstract_t">Yang KI, Grigg-Damberger M, Andrews N, et al. Severity of self-reported insomnia in adults with epilepsy is related to comorbid medical disorders and depressive symptoms. Epilepsy Behav 2016; 60:27.</a></li><li><a class="nounderline abstract_t">Sander JW. Comorbidity and premature mortality in epilepsy. Lancet 2013; 382:1618.</a></li><li><a class="nounderline abstract_t">Ottman R, Lipton RB, Ettinger AB, et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia 2011; 52:308.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Comorbidity in adults with epilepsy--United States, 2010. MMWR Morb Mortal Wkly Rep 2013; 62:849.</a></li><li><a class="nounderline abstract_t">Zack M, Luncheon C. Adults with an epilepsy history, notably those 45-64 years old or at the lowest income levels, more often report heart disease than adults without an epilepsy history. Epilepsy Behav 2018; 86:208.</a></li><li><a class="nounderline abstract_t">Chen Z, Liew D, Kwan P. Excess mortality and hospitalized morbidity in newly treated epilepsy patients. Neurology 2016; 87:718.</a></li><li><a class="nounderline abstract_t">Mintzer S, Yi M, Hegarty S, et al. Hyperlipidemia in patients newly treated with anticonvulsants: A population study. Epilepsia 2020; 61:259.</a></li><li><a class="nounderline abstract_t">Kanner AM, Bicchi MM. Antiseizure Medications for Adults With Epilepsy: A Review. JAMA 2022; 327:1269.</a></li><li><a class="nounderline abstract_t">Stecker EC, Reinier K, Uy-Evanado A, et al. Relationship between seizure episode and sudden cardiac arrest in patients with epilepsy: a community-based study. Circ Arrhythm Electrophysiol 2013; 6:912.</a></li><li><a class="nounderline abstract_t">Bardai A, Lamberts RJ, Blom MT, et al. Epilepsy is a risk factor for sudden cardiac arrest in the general population. PLoS One 2012; 7:e42749.</a></li><li><a class="nounderline abstract_t">Bardai A, Blom MT, van Noord C, et al. Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications. Heart 2015; 101:17.</a></li><li><a class="nounderline abstract_t">Verrier RL, Pang TD, Nearing BD, Schachter SC. The Epileptic Heart and the Case for Routine Use of the Electrocardiogram in Patients with Chronic Epilepsy. Neurol Clin 2022; 40:699.</a></li><li><a class="nounderline abstract_t">Verrier RL, Pang TD, Nearing BD, Schachter SC. The Epileptic Heart: Concept and clinical evidence. Epilepsy Behav 2020; 105:106946.</a></li><li><a class="nounderline abstract_t">Annegers JF, Melton LJ 3rd, Sun CA, Hauser WA. Risk of age-related fractures in patients with unprovoked seizures. Epilepsia 1989; 30:348.</a></li><li><a class="nounderline abstract_t">Kirby S, Sadler RM. Injury and death as a result of seizures. Epilepsia 1995; 36:25.</a></li><li><a class="nounderline abstract_t">Vestergaard P, Tigaran S, Rejnmark L, et al. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999; 99:269.</a></li><li><a class="nounderline abstract_t">Persson HB, Alberts KA, Farahmand BY, Tomson T. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia 2002; 43:768.</a></li><li><a class="nounderline abstract_t">Bell GS, Gaitatzis A, Bell CL, et al. Drowning in people with epilepsy: how great is the risk? Neurology 2008; 71:578.</a></li><li><a class="nounderline abstract_t">Friedman DE, Tobias RS, Akman CI, et al. Recurrent seizure-related injuries in people with epilepsy at a tertiary epilepsy center: a 2-year longitudinal study. Epilepsy Behav 2010; 19:400.</a></li><li><a class="nounderline abstract_t">Kwon CS, Liu M, Quan H, et al. The incidence of injuries in persons with and without epilepsy--a population-based study. Epilepsia 2010; 51:2247.</a></li><li><a class="nounderline abstract_t">Lawn ND, Bamlet WR, Radhakrishnan K, et al. Injuries due to seizures in persons with epilepsy: a population-based study. Neurology 2004; 63:1565.</a></li><li><a class="nounderline abstract_t">Beghi E, Cornaggia C, RESt-1 Group. Morbidity and accidents in patients with epilepsy: results of a European cohort study. Epilepsia 2002; 43:1076.</a></li><li><a class="nounderline abstract_t">Bowman SM, Aitken ME, Sharp GB. Disparities in injury death location for people with epilepsy/seizures. Epilepsy Behav 2010; 17:369.</a></li><li><a class="nounderline abstract_t">Fountain NB, Van Ness PC, Swain-Eng R, et al. Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology 2011; 76:94.</a></li><li><a class="nounderline abstract_t">Thurman DJ, Logroscino G, Beghi E, et al. The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 2017; 58:17.</a></li><li><a class="nounderline abstract_t">Levira F, Thurman DJ, Sander JW, et al. Premature mortality of epilepsy in low- and middle-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 2017; 58:6.</a></li><li><a class="nounderline abstract_t">Moon HJ, Lee H, Yoon D, et al. Premature Mortality and Causes of Death Among People With Epilepsy: A Nationwide Population-Based Incident Cohort Study. Neurology 2023; 100:e2060.</a></li><li><a class="nounderline abstract_t">Hauser WA, Annegers JF, Elveback LR. Mortality in patients with epilepsy. Epilepsia 1980; 21:399.</a></li><li><a class="nounderline abstract_t">Lhatoo SD, Johnson AL, Goodridge DM, et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001; 49:336.</a></li><li><a class="nounderline abstract_t">Olafsson E, Hauser WA, Gudmundsson G. Long-term survival of people with unprovoked seizures: a population-based study. Epilepsia 1998; 39:89.</a></li><li><a class="nounderline abstract_t">Pang EW, Lawn ND, Lee J, Dunne JW. Mortality after a first-ever unprovoked seizure. Epilepsia 2023; 64:1266.</a></li><li><a class="nounderline abstract_t">Gorton HC, Webb RT, Carr MJ, et al. Risk of Unnatural Mortality in People With Epilepsy. JAMA Neurol 2018; 75:929.</a></li><li><a class="nounderline abstract_t">Day SM, Wu YW, Strauss DJ, et al. Causes of death in remote symptomatic epilepsy. Neurology 2005; 65:216.</a></li><li><a class="nounderline abstract_t">Mu J, Liu L, Zhang Q, et al. Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology 2011; 77:132.</a></li><li><a class="nounderline abstract_t">Fazel S, Wolf A, Långström N, et al. Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet 2013; 382:1646.</a></li><li><a class="nounderline abstract_t">Mohanraj R, Norrie J, Stephen LJ, et al. Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study. Lancet Neurol 2006; 5:481.</a></li><li><a class="nounderline abstract_t">Keezer MR, Bell GS, Neligan A, et al. Cause of death and predictors of mortality in a community-based cohort of people with epilepsy. Neurology 2016; 86:704.</a></li><li><a class="nounderline abstract_t">Dreier JW, Laursen TM, Tomson T, et al. Cause-specific mortality and life years lost in people with epilepsy: a Danish cohort study. Brain 2023; 146:124.</a></li><li><a class="nounderline abstract_t">Annegers JF, Coan SP. SUDEP: overview of definitions and review of incidence data. Seizure 1999; 8:347.</a></li><li><a class="nounderline abstract_t">Leestma JE, Walczak T, Hughes JR, et al. A prospective study on sudden unexpected death in epilepsy. Ann Neurol 1989; 26:195.</a></li><li><a class="nounderline abstract_t">Nilsson L, Farahmand BY, Persson PG, et al. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 1999; 353:888.</a></li><li><a class="nounderline abstract_t">Walczak TS, Leppik IE, D'Amelio M, et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 2001; 56:519.</a></li></ol></div><div id="topicVersionRevision">Topic 114559 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23021287" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29917225" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Psychological treatments for adults and children with epilepsy: Evidence-based recommendations by the International League Against Epilepsy Psychology Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16026567" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22691064" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The somatic comorbidity of epilepsy: a weighty but often unrecognized burden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33734434" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Social outcome and psychiatric comorbidity of generalized epilepsies - A case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37209554" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Unemployment and early retirement among patients with epilepsy - A study on predictors, resilience factors and occupational reintegration measures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The personal impact of epilepsy: Correlations with seizure frequency, employment, cost of medical care, and satisfaction with physician care</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19178562" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Labor market participation following onset of seizures and early epilepsy: Findings from a UK cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21275976" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The social and economic consequences of epilepsy: a controlled national study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20227922" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Self-esteem and sense of coherence in young people with uncomplicated epilepsy: a 5-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22004000" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Development of an epilepsy-specific risk adjustment comorbidity index.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20067511" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Health status and health-related behaviors in epilepsy compared to other chronic conditions--a national population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20074233" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Alcohol consumption, unprovoked seizures, and epilepsy: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36427450" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Comorbidities in newly diagnosed epilepsy: Pre-existing health conditions are common and complex across age groups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37209553" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Hazard of substance abuse onset among adults diagnosed with epilepsy or migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8348903" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Clinical uses of the quality-of-life in epilepsy inventory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26333801" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Mindfulness-based therapy for drug-resistant epilepsy: An assessor-blinded randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26198593" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Neuropsychological and psychological interventions for people with newly diagnosed epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29078005" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Psychological treatments for people with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19260944" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Serious psychological distress among persons with epilepsy based on the 2005 California Health Interview Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19183219" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The association between depression and epilepsy in a nationally representative sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17662062" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Psychiatric comorbidity in epilepsy: a population-based analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29753295" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Major depressive disorder in epilepsy clinics: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36343531" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Psychiatric comorbidities among people with epilepsy: A population-based assessment in disadvantaged communities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36539302" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23175727" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Depression in epilepsy: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22578079" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Epilepsy and psychiatric comorbidity: a nationally representative population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19303457" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32248060" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Risk factors for depression in patients with epilepsy: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22282649" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22887468" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Epilepsy, suicidality, and psychiatric disorders: a bidirectional association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26844737" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Management of Epilepsy Comorbidities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18502183" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16483851" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Quality of life in medication-resistant epilepsy: the effects of patient's age, age at seizure onset, and disease duration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19170734" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20591744" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Differential effects of seizure control and affective symptoms on quality of life in people with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21883177" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30149996" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Common psychiatric comorbidities in epilepsy: How big of a problem is it?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22554067" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20138587" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Suicidal thoughts in epilepsy: a community-based study in Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23448169" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17611160" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Epilepsy and risk of suicide: a population-based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21288978" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Motor vehicle accidents, suicides, and assaults in epilepsy: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26650853" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Occurrence and Recurrence of Attempted Suicide Among People With Epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34023812" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Factors associated with suicidal ideation in an epilepsy center in Northern New England.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34023812" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Factors associated with suicidal ideation in an epilepsy center in Northern New England.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26530473" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Identifying clinical correlates for suicide among epilepsy patients in South Korea: A case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21955156" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25064739" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Validation of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adults with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28064446" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Depression screening tools in persons with epilepsy: A systematic review of validated tools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26994447" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12946886" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30600177" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Psychiatric comorbidities go untreated in patients with epilepsy: Ignorance or denial?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27836391" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Diagnosing and treating depression in epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33860531" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Antidepressants for people with epilepsy and depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34866176" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36571868" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Cognitive behavior therapy for depression in people with epilepsy: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25658682" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Retrospective Analysis of the Short-Term Safety of ECT in Patients With Neurological Comorbidities: A Guide for Pre-ECT Neurological Evaluations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16876485" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Electroconvulsive therapy in patients with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15964859" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22365727" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Evidence for shared susceptibility to epilepsy and psychosis: a population-based family study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24625201" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The prevalence of psychosis in epilepsy; a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17344100" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34288049" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Postictal Psychosis in Epilepsy: A Clinicogenetic Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27503872" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Psychotic disorders induced by antiepileptic drugs in people with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27179193" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Psychoses in epilepsy: A comparison of postictal and interictal psychoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11087773" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Predictive variables of interictal psychosis in epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11823107" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Frequency and age-related variables in interictal psychoses in localization-related epilepsies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20727828" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Postictal psychosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23663538" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Postictal psychosis in temporal lobe epilepsy: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17666070" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Interictal psychoses in comparison with schizophrenia--a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23739104" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Epilepsy and neuropsychological comorbidities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20045666" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : When do psychogenic nonepileptic seizures occur on a video/EEG telemetry unit?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20675198" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Latency to first psychogenic nonepileptic seizure upon admission to inpatient EEG monitoring: evidence for semiological differences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19583779" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16802302" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Cognitive prognosis in chronic temporal lobe epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21453356" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Newly diagnosed epilepsy: cognitive outcome after 12 months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11213111" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Neuropsychological effects of epilepsy and antiepileptic drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11971129" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Cognitive outcomes and predictive factors in epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16359429" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Behaviour, cognition and epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32028124" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Genetic and molecular basis of epilepsy-related cognitive dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32006792" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Antiepileptic drug effects on subjective and objective cognition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32015172" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Antiepileptic drugs are not independently associated with cognitive dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25779625" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28628538" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Memory Rehabilitation Strategies in Nonsurgical Temporal Lobe Epilepsy: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28658405" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Potential role of a cognitive rehabilitation program following left temporal lobe epilepsy surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18155965" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : The effects of cognitive rehabilitation on memory outcome after temporal lobe epilepsy surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28990169" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16504592" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12045998" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Sleep disordered breathing in neurologic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12800781" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Obstructive sleep apnea in epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11061259" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Obstructive sleep apnea is common in medically refractory epilepsy patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17984449" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Obstructive sleep apnea is associated with seizure occurrence in older adults with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Predictors of co-morbid obstructive sleep apnea in epilepsy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34256341" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Sleep duration and quality among U.S. adults with epilepsy: National Health Interview Survey 2013, 2015, and 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23636561" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Central sleep apnea and complex sleep apnea in patients with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24397915" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Use of the Sleep Apnea Scale of the Sleep Disorders Questionnaire (SA-SDQ) in adults with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25042599" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Continuous positive airway pressure therapy for obstructive sleep apnea reduces interictal epileptiform discharges in adults with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18711110" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Treating obstructive sleep apnea in adults with epilepsy: a randomized pilot trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21849000" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Effect of continuous positive airway pressure treatment on seizure control in patients with obstructive sleep apnea and epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Seizure reduction following nasal continuous positive airway pressure therapy for co-morbid obstructive sleep apnea in epilepsy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27176881" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Severity of self-reported insomnia in adults with epilepsy is related to comorbid medical disorders and depressive symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23883700" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Comorbidity and premature mortality in epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21269285" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24172878" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Comorbidity in adults with epilepsy--United States, 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29908906" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Adults with an epilepsy history, notably those 45-64 years old or at the lowest income levels, more often report heart disease than adults without an epilepsy history.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27421539" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Excess mortality and hospitalized morbidity in newly treated epilepsy patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31912492" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Hyperlipidemia in patients newly treated with anticonvulsants: A population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35380580" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Antiseizure Medications for Adults With Epilepsy: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23965297" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Relationship between seizure episode and sudden cardiac arrest in patients with epilepsy: a community-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22916156" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Epilepsy is a risk factor for sudden cardiac arrest in the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25031263" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36270685" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : The Epileptic Heart and the Case for Routine Use of the Electrocardiogram in Patients with Chronic Epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32109857" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : The Epileptic Heart: Concept and clinical evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2721468" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Risk of age-related fractures in patients with unprovoked seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8001504" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Injury and death as a result of seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10348155" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Fracture risk is increased in epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12102682" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Risk of extremity fractures in adult outpatients with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18711111" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Drowning in people with epilepsy: how great is the risk?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20851687" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Recurrent seizure-related injuries in people with epilepsy at a tertiary epilepsy center: a 2-year longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20726876" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : The incidence of injuries in persons with and without epilepsy--a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15534237" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Injuries due to seizures in persons with epilepsy: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12199734" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Morbidity and accidents in patients with epilepsy: results of a European cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20056495" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Disparities in injury death location for people with epilepsy/seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21205698" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27888514" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27988968" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Premature mortality of epilepsy in low- and middle-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36948594" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Premature Mortality and Causes of Death Among People With Epilepsy: A Nationwide Population-Based Incident Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7398606" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Mortality in patients with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11261508" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9578018" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Long-term survival of people with unprovoked seizures: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36861353" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Mortality after a first-ever unprovoked seizure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29630689" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Risk of Unnatural Mortality in People With Epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16043789" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Causes of death in remote symptomatic epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21653888" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Causes of death among people with convulsive epilepsy in rural West China: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23883699" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16713919" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26773074" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Cause of death and predictors of mortality in a community-based cohort of people with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35234848" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Cause-specific mortality and life years lost in people with epilepsy: a Danish cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10512776" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : SUDEP: overview of definitions and review of incidence data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2774506" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : A prospective study on sudden unexpected death in epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10093982" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Risk factors for sudden unexpected death in epilepsy: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11222798" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
